Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults
Clinical trial NCT04313127 · COMPLETED
Trial details
- NCT number
- NCT04313127
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-16
- Primary completion
- 2021-01-20
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.